Loss of function of CD2AP has been linked to enhanced Aβ production, tau-induced neurotoxicity, abnormal neurite structure modulation, and reduced blood-brain barrier integrity, which has been implicated in AD pathogenesis (Dubey et al., 2018; Ramos de Matos et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.